Agarwal Arjun bought ORKA

May 18, 2026 · Form 4 insider transaction

Agarwal Arjun bought 2,000 shares of Oruka Therapeutics, Inc. at $12.50 per share, a transaction worth $25.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Acquired (buy-side)
Shares
2,000
Price
$12.50
Total value
$25.0K
Role
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 18, 2026
Filing dateMay 18, 2026
Shares owned after20,863
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR